DB-1311
- Generic Name
- DB-1311
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- BioNTech SE
- Target Recruit Count
- 594
- Registration Number
- NCT06892548
- Locations
- 🇺🇸
Virginia Cancer Specialists, Fairfax, Virginia, United States
A Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- DualityBio Inc.
- Target Recruit Count
- 610
- Registration Number
- NCT05914116
- Locations
- 🇨🇳
Research Site 317, Xinxiang, Henan, China
🇺🇸Research Site 111, Tucson, Arizona, United States
🇺🇸Research Site 125, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath